Nabua, Baby Girl .
HRN: 25-76-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2024
AMPICILLIN 250MG (VIAL)
08/22/2024
08/28/2024
IV
150
Q12
SEPSIS OF THE NEWBORN
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes